BET-IN-23
Bet-in-23 (Compound 23) is a BD2-selective BET inhibitor with an IC50 of 2.9 nM. BET-IN-23 has anticancer activity and can significantly inhibit the proliferation of acute myeloid leukemia (AML) cell lines by inducing G0/G1 arrest and apoptosis in vitro[1].
Product Specifications
CAS Number
2953287-57-3
UNSPSC
12352005
Target
Apoptosis; Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Apoptosis; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bet-in-23.html
Solubility
10 mM in DMSO
Smiles
CN1C=C(C(NCC(N2CCOCC2)=O)=CC1=O)C3=C(C=CC(C(C)(O)C)=C3)OC4=C(C=C(C=C4C)F)C
Molecular Formula
C29H34FN3O5
Molecular Weight
523.60
References & Citations
[1]Jiang W, et al. Discovery of Novel Phenoxyaryl Pyridones as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with High Selectivity for the Second Bromodomain (BD2) to Potentially Treat Acute Myeloid Leukemia. J Med Chem. 2024 Jan 4.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC742208-100 1x 100 µL
E-Cadherin (CDH1) / CD324 (Intercellular Junction Marker) (CDH1/2208R), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
E-UNEL-M0037-01 5x 96 Tests
Uncoated Mouse NGF (Nerve growth factor) ELISA Kit
Sign In for Pricing
View Details E-UNEL-M0037-02 15x 96 Tests
Uncoated Mouse NGF (Nerve growth factor) ELISA Kit
Sign In for Pricing
View Details 